Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03100 | 34131333 | Nat Rev Endocrinol | Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. | 2021 | Details |
| A03101 | 34130852 | Semin Ultrasound CT MR | What's New in Hepatic Steatosis. | 2021 | Details |
| A03102 | 34130693 | Lipids Health Dis | Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. | 2021 | Details |
| A03103 | 34130208 | Nutr Res | A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice. | 2021 | Details |
| A03104 | 34129693 | Hepatology | Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A03105 | 34129272 | Hepatol Res | MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach. | 2021 | Details |
| A03106 | 34129252 | J Gastroenterol Hepatol | The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03107 | 34128328 | Chem Biodivers | Effect of Compounds from Moringa oleifera Lam. on in Vitro Non-Alcoholic Fatty Liver Disease (NAFLD) Model System. | 2021 | Details |
| A03109 | 34126522 | Surg Oncol | Continuous improvements in short and long-term outcomes after partial hepatectomy for hepatocellular carcinoma in the 21st century: Single institution experience with 1300 resections over 18 years. | 2021 | Details |
| A03110 | 34126247 | Endocr Pract | High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency. | 2021 | Details |
| A03111 | 34126105 | J Hepatol | Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. | 2021 | Details |
| A03112 | 34126083 | Am J Pathol | Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo Lipogenesis. | 2021 | Details |
| A03113 | 34125886 | J Clin Endocrinol Metab | New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease. | 2021 | Details |
| A03114 | 34125646 | Gut Microbes | Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A03115 | 34124830 | Hepatol Res | Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis. | 2021 | Details |
| A03116 | 34124059 | Front Cell Dev Biol | Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review. | 2021 | Details |
| A03117 | 34123670 | Cureus | Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey. | 2021 | Details |
| A03118 | 34122607 | Evid Based Complement Alternat Med | Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice. | 2021 | Details |
| A03119 | 34122138 | Front Physiol | Animal and Organoid Models of Liver Fibrosis. | 2021 | Details |
| A03120 | 34120768 | Mol Aspects Med | Autophagy in liver diseases: A review. | 2021 | Details |
| A03121 | 34120754 | Mayo Clin Proc | Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases. | 2021 | Details |
| A03122 | 34120361 | Res Nurs Health | Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaire. | 2021 | Details |
| A03123 | 34120339 | Eur J Clin Invest | Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort. | 2021 | Details |
| A03124 | 34120338 | Eur J Clin Invest | Fit mothers for a healthy future: Breaking the intergenerational cycle of non-alcoholic fatty liver disease with maternal exercise. | 2021 | Details |
| A03125 | 34119957 | Stem Cell Res | Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice. | 2021 | Details |
| A03126 | 34119888 | Biomaterials | A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids. | 2021 | Details |
| A03127 | 34119629 | J Nutr Biochem | Sugar kelp (Saccharina latissima) inhibits hepatic inflammation and fibrosis in a mouse model of diet-induced nonalcoholic steatohepatitis. | 2021 | Details |
| A03128 | 34119474 | Am J Pathol | Decreased Portal Circulation Augments Fibrosis and Ductular Reaction in Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A03129 | 34119399 | Acad Radiol | Comparison of the Effects of Hepatic Steatosis on Monoexponential DWI, Intravoxel Incoherent Motion Diffusion-weighted Imaging and Diffusion Kurtosis Imaging. | 2021 | Details |
| A03130 | 34118488 | Cell Mol Gastroenterol Hepatol | Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase. | 2021 | Details |
| A03131 | 34118476 | Mol Metab | Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH. | 2021 | Details |
| A03132 | 34118361 | Peptides | A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis. | 2021 | Details |
| A03133 | 34118335 | J Hepatol | Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease. | 2021 | Details |
| A03134 | 34118321 | Gastroenterol Hepatol | Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. | 2021 | Details |
| A03135 | 34118091 | J Intern Med | Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease. | 2021 | Details |
| A03136 | 34118015 | Updates Surg | Liver transplantation and bariatric surgery: a new surgical reality: a systematic review of the best time for bariatric surgery. | 2021 | Details |
| A03137 | 34117215 | Cell Death Dis | Liver fat storage is controlled by HNF4α through induction of lipophagy and is reversed by a potent HNF4α agonist. | 2021 | Details |
| A03138 | 34116975 | Dig Liver Dis | Association of sex hormones with hepatic steatosis in men with chronic hepatitis B. | 2021 | Details |
| A03139 | 34116355 | Biochem Biophys Res Commun | Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma. | 2021 | Details |
| A03142 | 34114650 | Cochrane Database Syst Rev | Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A03143 | 34114568 | Am J Gastroenterol | Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults. | 2021 | Details |
| A03145 | 34114341 | J Cell Mol Med | USP11 degrades KLF4 via its deubiquitinase activity in liver diseases. | 2021 | Details |
| A03146 | 34114325 | EMBO Rep | SCFJFK is functionally linked to obesity and metabolic syndrome. | 2021 | Details |
| A03147 | 34113839 | JHEP Rep | Evaluating causality of cellular senescence in non-alcoholic fatty liver disease. | 2021 | Details |
| A03148 | 34113260 | Front Physiol | Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders. | 2021 | Details |
| A03151 | 34112357 | Adv Food Nutr Res | Copper nutrition and biochemistry and human (patho)physiology. | 2021 | Details |
| A03152 | 34112075 | Kardiologiia | Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. | 2021 | Details |
| A03153 | 34108427 | J Chin Med Assoc | A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver disease. | 2021 | Details |
| A03155 | 34108094 | Dig Liver Dis | Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters. | 2021 | Details |
| A03156 | 34107939 | BMC Endocr Disord | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time. | 2021 | Details |
| A03157 | 34107897 | BMC Pediatr | Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study. | 2021 | Details |
| A03158 | 34107585 | Zhonghua Gan Zang Bing Za Zhi | [Protective effect of baicalein on high fat-induced hepatocytes oxidative damage]. | 2021 | Details |
| A03159 | 34107584 | Zhonghua Gan Zang Bing Za Zhi | [Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver]. | 2021 | Details |
| A03160 | 34107583 | Zhonghua Gan Zang Bing Za Zhi | [Relationship between triglyceride-glucose index and non-alcoholic fatty liver disease]. | 2021 | Details |
| A03161 | 34107545 | Semin Liver Dis | Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. | 2021 | Details |
| A03162 | 34107274 | Exp Cell Res | Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway. | 2021 | Details |
| A03163 | 34106786 | Am J Physiol Cell Physiol | Impaired Ca2+ signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment. | 2021 | Details |
| A03164 | 34106646 | Medicine (Baltimore) | The influence of RS738409 I148M polymorphism of patatin-like phospholipase domain containing 3 gene on the susceptibility of non-alcoholic fatty liver disease. | 2021 | Details |
| A03165 | 34106587 | Medicine (Baltimore) | Xuefu Zhuyu decoction for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2021 | Details |
| A03166 | 34106515 | Clin Obes | A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease. | 2021 | Details |
| A03167 | 34106414 | Cell Biochem Biophys | Thermally Oxidized Coconut Oil as Fat Source in High-Fat Diet Induces Hepatic Fibrosis in Diabetic Rat Model. | 2021 | Details |
| A03169 | 34105780 | Hepatology | Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis. | 2021 | Details |
| A03170 | 34104598 | Cureus | Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand. | 2021 | Details |
| A03172 | 34103552 | Sci Rep | Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico. | 2021 | Details |
| A03173 | 34101924 | Biofactors | alpha-Tocopherol supplementation reduces inflammation and apoptosis in high cholesterol mediated nonalcoholic steatohepatitis. | 2021 | Details |
| A03175 | 34100658 | Clin Pediatr (Phila) | Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018. | 2021 | Details |
| A03176 | 34099626 | Nutr Diabetes | Aging mitigates the severity of obesity-associated metabolic sequelae in a gender independent manner. | 2021 | Details |
| A03177 | 34099584 | J Physiol Pharmacol | Acute responses of hepatic fat content to consuming fat, glucose and fructose alone and in combination in non-obese non-diabetic individuals with non-alcoholic fatty liver disease. | 2021 | Details |
| A03178 | 34099068 | Hum Genomics | Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences. | 2021 | Details |
| A03179 | 34098712 | Clin Mol Hepatol | Recent advances in nonalcoholic fatty liver disease metabolomics. | 2021 | Details |
| A03180 | 34098145 | Mol Metab | Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression. | 2021 | Details |
| A03181 | 34097961 | Int J Biol Macromol | A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota. | 2021 | Details |
| A03182 | 34097928 | Prog Lipid Res | Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. | 2021 | Details |
| A03183 | 34096925 | J Vis Exp | A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium. | 2021 | Details |
| A03184 | 34096467 | Bioengineered | The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. | 2021 | Details |
| A03185 | 34096005 | Methods Mol Biol | Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A03186 | 34095739 | J Pancreat Cancer | Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis. | 2021 | Details |
| A03187 | 34095367 | Regen Ther | Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy. | 2021 | Details |
| A03188 | 34095305 | Biomed Res Int | A Combination of Geniposide and Chlorogenic Acid Combination Ameliorates Nonalcoholic Steatohepatitis in Mice by Inhibiting Kupffer Cell Activation. | 2021 | Details |
| A03189 | 34095297 | Biomed Res Int | A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study. | 2021 | Details |
| A03190 | 34095164 | Front Med (Lausanne) | Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients. | 2021 | Details |
| A03191 | 34095107 | Front Cell Dev Biol | Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet. | 2021 | Details |
| A03192 | 34095016 | Can J Gastroenterol Hepatol | Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis. | 2021 | Details |
| A03193 | 34094429 | Chem Sci | In situ visualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging. | 2020 | Details |
| A03194 | 34094167 | Chem Sci | Engineering a highly selective probe for ratiometric imaging of H2S n and revealing its signaling pathway in fatty liver disease. | 2020 | Details |
| A03195 | 34094026 | Iran J Basic Med Sci | The therapeutic effects of berberine plus sitagliptin in a rat model of fatty liver disease. | 2021 | Details |
| A03196 | 34093184 | Front Pharmacol | Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation. | 2021 | Details |
| A03197 | 34093169 | Front Pharmacol | Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway. | 2021 | Details |
| A03198 | 34093027 | Diabetes Metab Syndr Obes | Association Between Neck Circumference and Microalbuminuria in Community Residents. | 2021 | Details |
| A03199 | 34092976 | World J Gastroenterol | COVID-19 in normal, diseased and transplanted liver. | 2021 | Details |
| A03200 | 34092291 | Chin J Nat Med | Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. | 2021 | Details |
| A03202 | 34091530 | Chin Med J (Engl) | Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016. | 2021 | Details |
| A03203 | 34091049 | Clin Gastroenterol Hepatol | A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. | 2021 | Details |
| A03204 | 34091047 | Clin Gastroenterol Hepatol | The Placebo Response in Randomized Trials in Nonalcoholic Steatohepatitis Simply Explained. | 2021 | Details |
| A03205 | 34090928 | J Hepatol | Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03206 | 34090052 | Biomed Pharmacother | Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model. | 2021 | Details |
| A03207 | 34089894 | J Proteomics | Label-free quantitative proteomic analysis of serum extracellular vesicles differentiating patients of alcoholic and nonalcoholic fatty liver diseases. | 2021 | Details |
| A03209 | 34088912 | Sci Rep | A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models. | 2021 | Details |
| A03210 | 34088711 | J Epidemiol Community Health | Joint effect of changes in physical activity and weight on incident non-alcoholic fatty liver disease. | 2021 | Details |
| A03211 | 34088709 | BMJ Open | Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests. | 2021 | Details |